SCHEMBL8507196

SCHEMBL8507196

O=C(O)CCCCCCO[C@H]1O[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@@H]1OCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SSTR1 P30872 6/20 0.57
▸ SSTR2 P30874 6/20 0.57
▸ SSTR4 P31391 6/20 0.57
▸ SSTR3 P32745 6/20 0.57
▸ SSTR5 P35346 6/20 0.57
▸ NT5E P21589 1/20 0.52
▸ PTPN1 P18031 8/20 0.52
▸ CDC25B P30305 7/20 0.52
▸ PTPN2 P17706 5/20 0.52
▸ PTPN11 Q06124 5/20 0.52
▸ PTPN6 P29350 4/20 0.52
▸ TACR1 P25103 2/20 0.51
▸ ADRB2 P07550 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6139789 1.00 SSTR1 (0.57) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL5556504 1.00 SSTR1 (0.57) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL15444989 0.89 SSTR4 (0.47) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7908620 0.88 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7908639 0.88 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL6545135 0.88 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7908611 0.88 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7908607 0.88 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7908613 0.88 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL6545131 0.88 SSTR1 (0.60) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999001160-A1 SACCHARIDE CONJUGATES, PHARMACEUTICALS CONTAINING THE SAME, PROCESS FOR PREPARING THE SAME AND THEIR USE SCHERING AKTIENGESELLSCHAFT (DE) 1999-01-14 — — WO disclosed
Send feedback